user

Effect of natalizumab on disease activity in relapsing-remitting multiple sclerosis patients

被引：0
|
作者：
Agiela, Mabroka I. M. [1 ]
机构：
[1] Benghazi Med Ctr, Benghazi, Libya
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
12
引用
收藏
页码：NP5 / NP5
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN RUSSIA
    Matveev, N., V
    Sabanov, A., V
    Luneva, A., V
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A60 - A60
  • [22] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [23] Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis
    Bittner, S.
    Meuth, S.
    Seiler, C.
    Reiners, K.
    Wiendl, H.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S247 - S247
  • [24] Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study
    Hernandez-Preciado, Martha Rocio
    Marquez-Pedroza, Jazmin
    Sanchez-Rosales, Nayeli Alejandra
    Garcia-Rivera, Jose de Jesus
    Kobayashi-Gutierrez, Antonio
    Torres-Mendoza, Blanca Miriam
    Chavarria-Avila, Efrain
    Montano-Serrano, Raul Alejandro
    Cortes-Enriquez, Fernando
    Mireles-Ramirez, Mario Alberto
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [25] Effect of Natalizumab on Clinical and Radiological Disease Activity in a French Cohort of Relapsing Remitting Multiple Sclerosis Patients
    Melin, Annick
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Fleury, Marie
    Zephir, Helene
    Lacour, Arnaud
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Vermersch, Patrick
    De Seze, Jerome
    [J]. NEUROLOGY, 2011, 76 (09) : A71 - A71
  • [26] Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis
    Strijbis, Eva M.
    Coerver, Eline
    Mostert, Jop
    van Kempen, Zoe L. E.
    Killestein, Joep
    Comtois, Jacynthe
    Repovic, Pavle
    Bowen, James D.
    Cutter, Gary
    Koch, Marcus
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (10): : 792 - 799
  • [27] No evidence of disease activity and cognition in relapsing-remitting multiple sclerosis
    Alonso, R.
    Eizaguirre, B.
    Pita, C.
    Zavala, L.
    Silva, B.
    Marinangeli, A.
    Vanotti, S.
    Garcea, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 834 - 834
  • [28] Effect of intravenous methylprednisolone on MRI metrics of disease activity in relapsing-remitting multiple sclerosis patients
    Frank, JA
    Rao, AB
    Howard, T
    Bash, CN
    Richert, ND
    Lewis, BK
    McFarland, HF
    [J]. NEUROLOGY, 2001, 56 (08) : A460 - A460
  • [29] POSITIVE EFFECT OF ESCITALOPRAM ON DISEASE ACTIVITY IN WOMEN WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Mitsonis, C.
    Zervas, I.
    Potagas, C.
    Dimopoulos, N.
    Psara, V.
    Gkeka, A. E.
    Papadimitriou, G.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [30] Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis
    Zhang, Yinan
    Cofield, Stacey
    Cutter, Gary
    Krieger, Stephen
    Wolinsky, Jerry S.
    Lublin, Fred
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E58 - E65
12345